|
FTDR
Frontdoor, Inc.
FTDR · Q3 FY2025
|
Q3 FY2025 |
|
FTDR Q3 FY2025 transcript
|
|
MDT
Medtronic plc
MDT · Q2 FY2026
|
Q2 FY2026 |
|
MDT Q2 FY2026 transcript
|
|
ENR
Energizer Holdings, Inc.
ENR · Q4 FY2025
|
Q4 FY2025 |
|
ENR Q4 FY2025 transcript
|
|
HSDT
Solana Co
HSDT · Q3 FY2025
|
Q3 FY2025 |
|
HSDT Q3 FY2025 transcript
|
|
EONR
EON Resources Inc.
EONR · Q3 FY2025
|
Q3 FY2025 |
|
EONR Q3 FY2025 transcript
|
|
OCSL
Oaktree Specialty Lending Corp
OCSL · Q4 FY2025
|
Q4 FY2025 |
|
OCSL Q4 FY2025 transcript
|
|
BRBR
Bellring Brands, Inc.
BRBR · Q4 FY2025
|
Q4 FY2025 |
|
BRBR Q4 FY2025 transcript
|
|
FUTU
Futu Holdings Ltd
FUTU · Q3 FY2025
|
Q3 FY2025 |
|
FUTU Q3 FY2025 transcript
|
|
BENF
Beneficient
BENF · Q2 FY2026
|
Q2 FY2026 |
|
BENF Q2 FY2026 transcript
|
|
WYY
Widepoint Corp
WYY · Q3 FY2025
|
Q3 FY2025 |
|
WYY Q3 FY2025 transcript
|
|
POWL
Powell Industries Inc
POWL · Q4 FY2025
|
Q4 FY2025 |
|
POWL Q4 FY2025 transcript
|
|
PDD
PDD Holdings Inc.
PDD · Q3 FY2025
|
Q3 FY2025 |
|
PDD Q3 FY2025 transcript
|
|
LZB
La-Z-Boy Inc
LZB · Q2 FY2026
|
Q2 FY2026 |
|
LZB Q2 FY2026 transcript
|
|
ULBI
Ultralife Corp
ULBI · Q3 FY2025
|
Q3 FY2025 |
|
ULBI Q3 FY2025 transcript
|
|
DARE
Dare Bioscience, Inc.
DARE · Q3 FY2025
|
Q3 FY2025 |
|
DARE Q3 FY2025 transcript
|
|
NRXP
NRX Pharmaceuticals, Inc.
NRXP · Q3 FY2025
|
Q3 FY2025 |
|
NRXP Q3 FY2025 transcript
|
|
YSG
Yatsen Holding Ltd
YSG · Q3 FY2025
|
Q3 FY2025 |
|
YSG Q3 FY2025 transcript
|
|
CCOI
Cogent Communications Holdings, Inc.
CCOI · Q3 FY2025
|
Q3 FY2025 |
|
CCOI Q3 FY2025 transcript
|
|
JKS
JinkoSolar Holding Co., Ltd.
JKS · Q3 FY2025
|
Q3 FY2025 |
|
JKS Q3 FY2025 transcript
|
|
LFMD
LifeMD, Inc.
LFMD · Q3 FY2025
|
Q3 FY2025 |
|
LFMD Q3 FY2025 transcript
|
|
AIRI
Air Industries Group
AIRI · Q3 FY2025
|
Q3 FY2025 |
|
AIRI Q3 FY2025 transcript
|
|
ARMK
Aramark
ARMK · Q4 FY2025
|
Q4 FY2025 |
|
ARMK Q4 FY2025 transcript
|
|
VRME
VerifyMe, Inc.
VRME · Q3 FY2025
|
Q3 FY2025 |
|
VRME Q3 FY2025 transcript
|
|
GLAD
Gladstone Capital Corp
GLAD · Q4 FY2025
|
Q4 FY2025 |
|
GLAD Q4 FY2025 transcript
|